Comparison of Two Formulations of AZD5363 and the Effect of Food on Pharmacokinetic Exposure, Safety and Tolerability

NCT01895946 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Malignancy,
Safety and Tolerability,
Pharmacokinetics, Pharmacodynamics,
Tumour Response,

Interventions

DRUG: AZD5363
DRUG: AZD5363

Sponsor

AstraZeneca